<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the sto [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
How to turn off a VPN on iPhone

Look, virtual private networks are great — I wouldn't have made a list of the best VPNs if I didn't recommend using them. But being able to control your own technology is also important. A [...]

Match Score: 42.01

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 41.72

venturebeat
MCP solved tool calling. A2A solved coordination. What solves transport?

The history of distributed computing is one of protocol proliferation followed by consolidation. Common Object Request Broker Architecture (CORBA), Distributed Component Object Model (DCOM), Java remo [...]

Match Score: 33.60

thenextweb
Apple’s Private Relay is supposed to hide your IP. Researchers found three ways it doesn’t

Apple’s Private Relay is supposed to hide your IP address. Researchers have found three ways it does not. The paid feature, part of an iCloud+ subscription, masks your real IP address while you brow [...]

Match Score: 33.60

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 33.38

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 33.38

qz
Unity Software (U) Surges 13.5%: Is This an Indication of Further Gains?

Unity Software (U) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock [...]

Match Score: 33.07

qz
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Madrigal (MDGL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not [...]

Match Score: 33.07

qz
Innventure, Inc. (INV) Surges 13.3%: Is This an Indication of Further Gains?

Innventure, Inc. (INV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the st [...]

Match Score: 33.07